Reference
Piwko C, et al. Safety profile and costs of related adverse events of trastuzumab emtansine compared to other regimens in the Canadian health care system. 36th Annual San Antonio Breast Cancer Symposium : abstr. P4-12-16, 10 Dec 2013.
Rights and permissions
About this article
Cite this article
Trastuzumab emtansine: cost savings from fewer AEs. Reactions Weekly 1488, 5 (2014). https://doi.org/10.1007/s40278-014-8754-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-8754-y